Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

This study examined the feasibility of non-invasive infrared thermography to monitor skin graft viability. Sixty-three patients with skin defects attending a single institution from May 2022 to August 2023 were included. Patients underwent full-thickness or split-thickness skin grafts based on clinical indication. Infrared thermal images were obtained on postoperative days 0, 2, 4, 6 and 8. The temperature difference between the skin graft and surrounding normal skin was assessed using image analysis software. All 33 patients with full-thickness skin grafts showed successful healing. Among the 30 patients with split-thickness skin grafts, 7 experienced failure. The groups with successful full-thickness and split-thickness skin grafts exhibited a gradual increase in graft temperature, peaking on postoperative day 6 and decreasing on postoperative day 8. Temporal temperature changes were significant in each patient group (p < 0.001), and the differences in temperature change patterns between the two groups with successful grafts and the group with graft failure were also significant (p < 0.001). On postoperative day 6, the temperature difference was highest in the full-thickness skin graft group (0.197 ± 0.335°C), followed by the successful split-thickness skin graft group (0.426 ± 0.428°C), and the split-thickness skin graft group with graft failure (-2.100 ± 0.361°C). In conclusion, infrared thermal imaging can provide a non-invasive real-time assessment of graft status and predict graft success or failure.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11581778PMC
http://dx.doi.org/10.1111/iwj.70107DOI Listing

Publication Analysis

Top Keywords

skin grafts
16
skin graft
12
split-thickness skin
12
skin
9
infrared thermal
8
full-thickness split-thickness
8
postoperative day
8
graft monitoring
4
monitoring forward-looking
4
forward-looking infrared
4

Similar Publications

Transformative Therapies for Wound Care: Insights into Tissue Engineering and Regenerative Medicine.

Adv Exp Med Biol

September 2025

Department of Stem Cells & Regenerative Medicine, Center for Interdisciplinary Research, D. Y. Patil Education Society (Deemed to be University), Kolhapur, Maharashtra, India.

Wound healing is a dynamic and complex process that consists of four interconnected phases: hemostasis, inflammation, proliferation, and remodeling. This complex process is based on the coordinated actions of growth factors, cytokines, and other cellular interactions. However, conditions such as diabetes and chronic illnesses can disrupt this process and lead to nonhealing wounds or chronic ulcers.

View Article and Find Full Text PDF

Background: The suppressor of tumorigenesis 2 (ST2) has emerged as one of the most promising biomarkers for predicting mortality of acute graft-versus-host disease (aGvHD) when measured at the onset of symptoms, but detailed time course studies are needed to understand the potential of ST2 as a risk marker of both aGvHD and chronic graft-versus-host disease (cGvHD), potentially allowing pre-emptive adjustment of immunosuppressive treatment.

Procedure: We measured ST2 levels in 117 children undergoing standard hematopoietic stem cell transplantation (HSCT) before conditioning and at regular intervals post-HSCT.

Results: ST2 levels were significantly increased from Day +7 in patients developing aGvHD of any grade (no GvHD: 23.

View Article and Find Full Text PDF

Introduction: Complex soft tissue injuries in the facial area can arise from various causes. Surgeons face significant challenges when reconstructing these injuries, as they must select appropriate materials based on texture and color, while also considering their composition and properties. The anterolateral thigh (ALT) flap has emerged as a versatile option in clinical reconstructive surgery, offering many advantages over other free flaps.

View Article and Find Full Text PDF

Risankizumab (RZB) is a humanized monoclonal antibody that selectively targets interleukin-23 (IL-23). It has proven particularly effective in treating psoriasis, a common chronic inflammatory skin disease. However, its use remains poorly documented in certain populations, including patients with a history of solid organ transplantation or recent/active malignancy.

View Article and Find Full Text PDF

Background Diabetic foot ulcers (DFUs) are a major complication of diabetes, posing significant challenges due to impaired wound healing, increased infection risk, and frequent need for surgical intervention. Optimal wound care is essential to reduce morbidity, hospital stay, and healthcare costs. While povidone iodine is a common antiseptic dressing, Metrogyl (metronidazole) targets anaerobic bacteria and may offer superior outcomes in chronic, infected wounds.

View Article and Find Full Text PDF